Loading...
Fourrts (india) Laboratories Private Limited — Ibuprofen Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #10 for Ibuprofen · $4.4M export value · DGFT Verified
Fourrts (india) Laboratories Private Limited is the #10 Indian exporter of Ibuprofen with $4.4M in export value and 88 verified shipments. Fourrts (india) Laboratories Private Limited holds a 0.8% market share in Ibuprofen exports across 18 countries. The company exports 17 pharmaceutical products worth $31.5M across 11 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| TANZANIA | $122.2K | 3 | 37.5% |
| MOZAMBIQUE | $109.2K | 6 | 33.5% |
| UNITED KINGDOM | $65.3K | 6 | 20.0% |
| ZAMBIA | $14.6K | 1 | 4.5% |
| SRI LANKA | $8.3K | 3 | 2.5% |
| BURKINA FASO | $3.4K | 1 | 1.1% |
| IRAQ | $1.7K | 1 | 0.5% |
| CAMBODIA | $1.5K | 1 | 0.5% |
Fourrts (india) Laboratories Private Limited exports Ibuprofen to 8 countries. The largest destination is TANZANIA accounting for 37.5% of Fourrts (india) Laboratories Private Limited's Ibuprofen shipments, followed by MOZAMBIQUE (33.5%) and UNITED KINGDOM (20.0%). These destinations reflect Fourrts (india) Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| GENERIC SPECIALITIES LDA | MOZAMBIQUE | $109.2K | 6 |
| BROWN BURK UK LTD | UNITED KINGDOM | $65.3K | 6 |
| M S MORAF PHARMACEUTICALS LTD | TANZANIA | $50.0K | 1 |
| MORAF PHARMACEUTICALS LTD | TANZANIA | $50.0K | 1 |
| INTERMED MEDICAL SUPPLIES AND MEDIC | TANZANIA | $22.2K | 1 |
| KARIBU PHARMACEUTICALS LTD | ZAMBIA | $14.6K | 1 |
India exported $212.2M worth of Ibuprofen through 15,000 shipments from 762 suppliers to 173 countries, serving 2,116 buyers globally. Fourrts (india) Laboratories Private Limited contributes $4.4M to this total, accounting for 0.8% of India's Ibuprofen exports. Fourrts (india) Laboratories Private Limited ships Ibuprofen to 8 countries through 11 buyers.
Fourrts (india) Laboratories Private Limited's average Ibuprofen shipment value is $50.0K per consignment, based on 88 shipments totaling $4.4M. The largest destination is TANZANIA (37.5% of Fourrts (india) Laboratories Private Limited's Ibuprofen exports).
Fourrts (india) Laboratories Private Limited ranks #10 among 762 Indian Ibuprofen exporters with a 0.8% market share. The top 3 exporters are MARKSANS PHARMA LIMITED ($53.8M), GRANULES INDIA LIMITED ($34.9M), CAPLIN POINT LABORATORIES LIMITED ($31.4M). Fourrts (india) Laboratories Private Limited processed 88 shipments to 18 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| IBUPROFEN TABLETS BP 400 MG BRUGEN 400 37054 X 10 X 10S | $52.5K | 2 |
| IBUPROFEN TABLETS BP 200MG IBUFIL 200 79441 X 10 X 10 S | $50.0K | 1 |
| IBUPROFEN TABLETS BP 200MG IBUFIL 200 99200 X 10 X 10S | $50.0K | 1 |
| IBUPROFEN 400MG TABLETS QTY 55662 X7 X 12S | $47.7K | 1 |
| IBUPROFEN TABLETS BP 400 MG BRUGEN 400 66000 X 10 X 10S | $46.3K | 1 |
| IBUPROFEN TABLETS BP 200MG IBUFIL F 200 | $22.2K | 1 |
| IBUPROFEN TABLETS BP 200MG IBUFIL 200 WE INTEND TO CLAIM REWARDS UNDER RODTEP | $14.6K | 1 |
| IBUPROFEN 200MG TABLETS QTY 18575 X7 X 12S | $11.4K | 1 |
What Fourrts (india) Laboratories Private Limited must comply with to export Ibuprofen to its top destination countries
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 14 | QUALIGENS PHARMA PRIVATE LIMITED | $5.6M | 129 | 4 | $43.5K |
| 15 | ADCOCK INGRAM LIMITED | $5.5M | 357 | 1 | $15.3K |
| 10 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED ★ | $4.4M | 88 | 18 | $50.0K |
| 12 | WEXFORD LABORATORIES PRIVATE LIMITED | $4.2M | 83 |
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 2,511 | 16.7% |
| JNPT/ NHAVA SHEVA SEA | 1,756 | 11.7% |
| JNPT | 774 | 5.2% |
| SAHAR AIR | 637 | 4.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 593 | 4.0% |
| BANGALORE ICD | 472 | 3.1% |
| NHAVA SHEVA | 422 | 2.8% |
| CHENNAI SEA | 419 | 2.8% |
Fourrts (india) Laboratories Private Limited also exports these analgesics & antipyretics products. Each links to the detailed product page.
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Fourrts. The Israel-Iran conflict has led to disruptions in Middle Eastern trade routes, particularly affecting the Red Sea corridor. Major shipping lines have introduced 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, effectively increasing the cost of exporting pharmaceuticals to key markets. (sgeexport.com)
Conversely, the recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable outlook. The FTA eliminates tariffs on approximately 97% of European exports, including pharmaceuticals, potentially doubling India's exports to the EU by 2032. This development provides Fourrts with an opportunity to expand its footprint in European markets, offsetting challenges in other regions. (en.wikipedia.org)
In the United States, the imposition of tariffs on pharmaceutical imports has prompted a reshoring of manufacturing. While this trend may reduce reliance on Indian generics, it also opens avenues for Indian companies to invest in U.S.-based facilities, thereby maintaining market access. Fourrts could consider strategic investments or partnerships to navigate this evolving landscape. (odrindia.in)
Compliance with international regulatory standards is paramount for sustaining export operations. The WHO's alert regarding the 'COLD OUT' syrup underscores the necessity for rigorous quality control and adherence to Good Manufacturing Practices (GMP). Indian pharmaceutical companies are increasingly investing in compliance automation and supply chain restructuring to meet the stringent requirements of markets like the EU and the U.S. (transdatanexus.com)
For Fourrts, maintaining and enhancing compliance protocols is essential to mitigate risks and capitalize on global market opportunities. Proactive engagement with regulatory bodies and continuous improvement in quality assurance processes will be critical in navigating the complex regulatory environment.
Fourrts (india) Laboratories Private Limited exports 17 products worth $31.5M. Beyond Ibuprofen, top products include Metformin, Paracetamol, Cetirizine, Naproxen, Atenolol. View the complete Fourrts (india) Laboratories Private Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Ibuprofen — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Fourrts (india) Laboratories Private Limited's Ibuprofen exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Fourrts (india) Laboratories Private Limited
Full Company Profile →
17 products · $31.5M total trade · 11 categories
| M S SUNSHINE HEALTHCARE LANKA LTD | SRI LANKA | $5.5K | 1 |
| CAMEG | BURKINA FASO | $3.4K | 1 |
| SUNSHINE HEALTHCARE LANKA LTD | SRI LANKA | $2.8K | 2 |
| HAJAR AL FADHI COMPANY | IRAQ | $1.7K | 1 |
Fourrts (india) Laboratories Private Limited supplies Ibuprofen to 11 buyers globally. The largest buyer is GENERIC SPECIALITIES LDA (MOZAMBIQUE), followed by BROWN BURK UK LTD (UNITED KINGDOM) and M S MORAF PHARMACEUTICALS LTD (TANZANIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| IBUPROFEN 600MG TABLETS QTY 6371 X 7X 12S |
| $6.2K |
| 1 |
| IBUPROFEN ORAL SUSPENSION BP IBROFAN 16480 X 60ML | $5.5K | 1 |
Fourrts (india) Laboratories Private Limited exports 20 distinct Ibuprofen formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IBUPROFEN TABLETS BP 400 MG BRUGEN 400 37054 X 10 X 10S with 2 shipments worth $52.5K.
| 5 |
| $50.0K |
| 11 | VIVIMED LIFE SCIENCES PRIVATE LIMITED | $3.3M | 66 | 1 | $50.0K |
Fourrts (india) Laboratories Private Limited ranks #10 among 762 Indian Ibuprofen exporters. Average shipment value of $50.0K compared to the market average of $278.5K. The closest competitors by value are QUALIGENS PHARMA PRIVATE LIMITED and ADCOCK INGRAM LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 173+ countries, 2,116+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Fourrts (india) Laboratories Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ibuprofen. For current shipment-level data, contact TransData Nexus.